130 related articles for article (PubMed ID: 38331402)
1. Spirited discussion: lymph node count versus nodal station count.
D'Ambrosio PD; Vieira A; Ugalde Figueroa P
Interdiscip Cardiovasc Thorac Surg; 2024 Feb; 38(2):. PubMed ID: 38331402
[No Abstract] [Full Text] [Related]
2. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.
Heiden BT; Eaton DB; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
J Thorac Oncol; 2022 Nov; 17(11):1287-1296. PubMed ID: 36049657
[TBL] [Abstract][Full Text] [Related]
4. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.
Yuan S; Meng X; Yu J; Mu D; Chao KS; Zhang J; Zhong W; Yu Y; Wang J; Sun X; Yang G; Wang Y
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):727-34. PubMed ID: 17293231
[TBL] [Abstract][Full Text] [Related]
5. Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer.
Nomori H; Horio H; Naruke T; Orikasa H; Yamazaki K; Suemasu K
J Thorac Cardiovasc Surg; 2002 Sep; 124(3):486-92. PubMed ID: 12202864
[TBL] [Abstract][Full Text] [Related]
6. Effect of examining lymph nodes count on mortality risk in resected T1 non-small-cell lung cancer.
Zeng J; Liu Q; Chang R; Chen Y; Yu Z; Yi B; Gao Y
Interdiscip Cardiovasc Thorac Surg; 2024 Feb; 38(2):. PubMed ID: 38039183
[TBL] [Abstract][Full Text] [Related]
7. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
[TBL] [Abstract][Full Text] [Related]
8. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of nodal metastases in lymph node stations 8 & 9 in a large UK lung cancer surgical centre without routine pre-operative EUS nodal staging.
Evison M; Edwards T; Balata H; Tempowski A; Teng B; Bishop P; Fontaine E; Krysiak P; Rammohan K; Shah R; Crosbie P; Booton R
Lung Cancer; 2018 Jan; 115():127-130. PubMed ID: 29290254
[TBL] [Abstract][Full Text] [Related]
10. Variability in defining T1N0 non-small cell lung cancer impacts locoregional failure and survival.
Saynak M; Hubbs J; Nam J; Marks LB; Feins RH; Haithcock BE; Veeramachaneni NK
Ann Thorac Surg; 2010 Nov; 90(5):1645-9; discussion 1649-50. PubMed ID: 20971280
[TBL] [Abstract][Full Text] [Related]
11. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation.
Watanabe S; Ladas G; Goldstraw P
Ann Thorac Surg; 2002 Jan; 73(1):245-8; discussion 248-9. PubMed ID: 11834017
[TBL] [Abstract][Full Text] [Related]
12. The impact of dissection of station 9 on survival and the necessity of pulmonary ligament division during upper lobectomy for lung cancer.
Yazgan S; Üçvet A; Türk Y; Gürsoy S
Acta Chir Belg; 2023 Apr; 123(2):148-155. PubMed ID: 34288832
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
14. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
[TBL] [Abstract][Full Text] [Related]
15. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
[TBL] [Abstract][Full Text] [Related]
16. Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.
Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K
J Thorac Oncol; 2006 Nov; 1(9):949-52. PubMed ID: 17409977
[TBL] [Abstract][Full Text] [Related]
17. [Impact of the examined number of lymph nodes at N1 station on the prognosis of patients with pT1-3N0M0 non-small cell lung cancer].
Wang GX; Li T; Xu SB; Wang J; Xiong R; Xu MQ; Xie MR
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):155-159. PubMed ID: 35184459
[No Abstract] [Full Text] [Related]
18. Proposals for changes in the Mountain and Dresler mediastinal and pulmonary lymph node map.
Zieliński M; Rami-Porta R
J Thorac Oncol; 2007 Jan; 2(1):3-6. PubMed ID: 17410002
[TBL] [Abstract][Full Text] [Related]
19. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].
Shen L; Yun T; Guo J; Liu Y; Liang C
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1793-1798. PubMed ID: 33380404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
